Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Neoadjuvant immunotherapy delivers in cisplatin-ineligible bladder cancer

Neoadjuvant immunotherapy delivers in cisplatin-ineligible bladder cancer

03 Mar 2023
Nivolumab plus cabozantinib superior to sunitinib in renal cell carcinoma

Nivolumab plus cabozantinib superior to sunitinib in renal cell carcinoma

03 Mar 2023 bởiStephen Padilla

First-line treatment of advanced renal cell carcinoma (aRCC) with nivolumab plus cabozantinib (N+C) results in sustained survival and response benefits at 3 years minimum follow-up, which is consistent with previous follow-ups, according to a study presented at the 2023 ASCO GU Cancers Symposium.

Nivolumab plus cabozantinib superior to sunitinib in renal cell carcinoma

03 Mar 2023
Infertility implicated in obesity-related reproductive cancers

Infertility implicated in obesity-related reproductive cancers

03 Mar 2023

Women with a history of infertility are more likely to develop reproductive cancers that are related to obesity, as reported in a study.

Infertility implicated in obesity-related reproductive cancers

03 Mar 2023